Cited by 1,037Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.

Tau pathology in Alzheimer disease and other tauopathies

Open access

Iqbal, Khalid, del C. Alonso, Alejandra, Chen, She, Chohan, M. Omar, El-Akkad, Ezzat, Gong, Cheng-Xin, Khatoon, Sabiha, Li, Bin, Liu, Fei, Rahman, Abdur, Tanimukai, Hitoshi, Grundke-Iqbal, Inge·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI 10.1016/j.bbadis.2004.09.008

Open this paper in CoChat — free account

Abstract

Just as neuronal activity is essential to normal brain function, microtubule-associated protein tau appears to be critical to normal neuronal activity in the mammalian brain, especially in the evolutionary most advanced species, the homo sapiens. While the loss of functional tau can be compensated by the other two neuronal microtubule-associated proteins, MAP1A/MAP1B and MAP2, it is the dysfunctional, i.e., the toxic tau, which forces an affected neuron in a long and losing battle resulting in a slow but progressive retrograde neurodegeneration. It is this pathology which is characteristic of Alzheimer disease (AD) and other tauopathies. To date, the most established and the most compelling cause of dysfunctional tau in AD and other tauopathies is the abnormal hyperphosphorylation of tau. The abnormal hyperphosphorylation not only results in the loss of tau function of promoting assembly and stabilizing microtubules but also in a gain of a toxic function whereby the pathological tau sequesters normal tau, MAP1A/MAP1B and MAP2, and causes inhibition and disruption of microtubules. This toxic gain of function of the pathological tau appears to be solely due to its abnormal hyperphosphorylation because dephosphorylation converts it functionally into a normal-like state. The affected neurons battle the toxic tau both by continually synthesizing new normal tau and as well as by packaging the abnormally hyperphosphorylated tau into inert polymers, i.e., neurofibrillary tangles of paired helical filaments, twisted ribbons and straight filaments. Slowly but progressively, the affected neurons undergo a retrograde degeneration. The hyperphosphorylation of tau results both from an imbalance between the activities of tau kinases and tau phosphatases and as well as changes in tau's conformation which affect its interaction with these enzymes. A decrease in the activity of protein phosphatase-2A (PP-2A) in AD brain and certain missense mutations seen in frontotemporal dementia promotes the abnormal hyperphosphorylation of tau. Inhibition of this tau abnormality is one of the most promising therapeutic approaches to AD and other tauopathies.

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2004.09.008

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,543
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780

Show all 154 references

Sorted by citations

Items 801–900 of 999

Nanomedical drug delivery for neurodegenerative disease
Kaur, N., Kumar, V., Mahender, T., Maji, I., Mahajan, S., Aalhate, M., Singh, P. K., & Sahu, S. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00016-2 · Cited by 2
Mechanistic insights into the inhibition of microtubule affinity-regulating kinase 4 by Syringic acid: A computational and experimental study
Shahwan, M. J., Yadav, D. K., Khan, M. S., Choudhury, A., Shamsi, A., Hassan, M. I., & Anwar, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142812 · Cited by 2
Single-Cell Transcriptome Patterns of Transposable Elements in Alzheimer’s Disease
McEntee, C. M., & LaRocca, T. J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05140-9 · Cited by 4
Misfolded Proteins in Neurodegenerative Dementias: Molecular Mechanisms
Yang, H. D., Ho, D. H., Yi, M. J., Seol, W., & Kim, S. (2012) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2012.11.2.38 · Cited by 2
Emerging pathways in genetic Parkinson’s disease
Lewis, P. A. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06706.x · Cited by 2
Spatially pathogenic forms of tau detected in Alzheimer's disease brain tissue by fluorescence lifetime-based Förster resonance energy transfer
Larionov, S., Wielgat, P., Wang, Y., Thal, D. R., & Neumann, H. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.07.021 · Cited by 3
Flow cytometry-based method to analyze the change in Tau phosphorylation in a hGSK-3β and hTau over-expressing EcR-293 cell line
Kurkó, D., Boros, A. M., Dezső, P., Urbányi, Z., Sárvári, M., Nagy, J., Szombathelyi, Z., & Szendrei, G. I. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.11.010 · Cited by 2
The Influence of Widowhood and Sociodemographic Moderators on Dementia and Alzheimer's Disease Risk
Hatch, D. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/7885-c750 · Cited by 2
Fisiopatología de la enfermedad de Alzheimer
Álvarez, M., Ibáñez, I. P., de la Fe, A., Sánchez, A. P., Sánchez, M. Á., & Alvarez, L. M. (2008) · Cited by 2
Species, Strain, and Gender Issues in the Development and Validation of Animal Models of Dementia
Dijck, A. V., Dam, D. V., & Deyn, P. P. D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_4 · Cited by 2
Dementia: Alzheimer's disease
Lovestone, S. (2012) · doi:10.1093/med/9780199696758.003.0042 · Cited by 2
Tyrosine Kinase Inhibitors and Neurodegenerative Disorders
Mehdi, S. J., Barger, S. W., Paule, M. G., Ali, S. F., & Imam, S. Z. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_5 · Cited by 2
Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease
Kazim, S. F., & Iqbal, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00002-8 · Cited by 2
Arousal and the Alzheimer disease
García‐Rill, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817992-5.00008-8 · Cited by 2
Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease
Sose, P. M., Kale, P. P., & Doshi, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527323666230904150841 · Cited by 2
Histological and Memory Alterations in an Innovative Alzheimer’s Disease Animal Model by Vanadium Pentoxide Inhalation
Dorado-Martínez, C., Montiel-Flores, E., Ordóñez-Librado, J. L., Gutiérrez-Valdez, A. L., Caballero, C. A. G., Sánchez-Betancourt, J., Erazo, L. R., Tron-Alvarez, R., Rodríguez-Lara, V., & Ávila-Costa, M. R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230818 · Cited by 3
Contributions of AMP kinase to the Pathogenesis of Type 2 Diabetes and Neurodegenerative Diseases
Kodiha, M., Mahboubi, H., & Stochaj, U. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch22 · Cited by 2
Emotion and Behavior in Alzheimer's Disease and Other Dementias
Wright, C. I. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch14 · Cited by 2
Mitochondria in Alzheimer disease : regulatory mechanisms and cell death
Hedskog, L. (2012) · Figshare · Cited by 2
Alzheimer's Disease BACE Proteases
Roßner, S., & Lichtenthaler, S. F. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_11 · Cited by 1
Tau-Centric Therapies for Treating Alzheimer’s Disease
Quraishe, S., Cowan, C. M., & Mudher, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00005-3 · Cited by 1
Exosomes: Future Perspective in Neurodegenerative Diseases
Alidoust, L., & Jafari, A. (2020) · Caspian Journal of Neurological Sciences · doi:10.32598/cjns.6.23.4 · Cited by 1
Prospective role of Citicoline and nanotechnology as drug delivery approaches for Alzheimer’s disease: Review of the literature
AbouElhassan, K. M., Sarhan, H. A., Hussein, A. K., Taye, A., & Safwat, M. A. (2022) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2022.150175.1162 · Cited by 1
Diagnosis of Alzheimer’s Disease, Types of Plaques and Their Detection, Imaging Techniques, and Other Tests
Qureshi, T., & Chinnathambi, S. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_7 · Cited by 1
Microbial Composition, Disease Trajectory and Genetic Background in a Slow Onset Model of Frontotemporal Lobar Degeneration
Daude, N., Machado, I., Arce, L., Yang, J., & Westaway, D. A. (2025) · Biomolecules · doi:10.3390/biom15050636 · Cited by 1
Progestogens reduce tau phosphorylation via ERK 1/2 in a tau overexpression cell model
Bassani, T. B., Oliveira, R. B., Portella, G. V., Nishino, M. S., Costa, A. J., & Ureshino, R. P. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100236 · Cited by 1
Polycyclitol Derivatives Restore Long- Term Memory Via cdk5/p25 Activation of Tau Signaling in Experimental Cerebral Malaria
Simhadri, P. K., Rashid, S., Karri, S., Bhat, B. A., Mehta, G., & Babu, P. P. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04495-8 · Cited by 1
In Silico Insights into Marine Natural Products as AChE and BChE Inhibitors
Parmar, P., & Patel, P. H. (2025) · Journal of Natural Remedies · doi:10.18311/jnr/2025/48378 · Cited by 1
A novel TGFβ1–Hs3st2–tau axis regulates tau pathology and synaptic integrity
Castillo‐Negrete, R., Merrick, H., Selvaraj, S., Huynh, M. B., Laffray, X., Thuraisamy, A., Diener, M., Jedlička, P., Ouidja, M. O., & Papy-García, D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1726022 · Cited by 1
Plasma p-tau217 assays effectively predict amyloid status but lack precision for tau staging in Alzheimer’s disease
Chen, Y., Wang, Z., Chen, H., Cui, H., Li, S., & Initiative, A. D. N. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13726-z · Cited by 1
APP E590D mutation increases generation of Aβ and Aη peptides and exacerbates tauopathy
Liu, T., Wetzel, L., Roy, D., Zhang, K., Zhu, Z., Kumaraguru, P., Gorthi, V., Jeon, H., Woo, J. A., & Kang, D. E. (2026) · npj Dementia · doi:10.1038/s44400-026-00069-9 · Cited by 1
Recent Progress on Selenium Nanoparticles: Synthesis and Neuroprotective Effects for the Treatment of Alzheimer’s Disease
Shah, D., Akarte, K., Patel, S., Patel, A., Kushwaha, N., Panjwani, D., Patel, V. A., Ahlawat, P., & Shah, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05835-7 · Cited by 1
Ultrasensitive Assay Technologies
Yang, C. S.-Y., & Sabbagh, M. N. (2026) · Springer eBooks · doi:10.1007/978-3-032-23863-4_1 · Cited by 1
Herpes simplex virus infection and Alzheimer’s disease
Hur, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1858017 · Cited by 1
Preliminary Development of a Hybrid Aptamer and Antibody Fluorescent Lateral Flow Assay for Ultrasensitive Detection of Tau441 Protein in Serum: Toward Point-of-Care Diagnostics for Alzheimer’s Disease
Mahrat, R., Chen, Y., Bruno, J. G., Nasaev, S. S., Ufaev, D., & Kudryashova, N. (2026) · Journal of Fluorescence · doi:10.1007/s10895-026-04925-y · Cited by 1
Alzheimer's disease
Matthews, B. R., & Miller, B. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.005 · Cited by 1
Diagnosis of Dementia Using Nuclear Medicine Imaging Modalities
Merissa, N., Garrett, M., & Scott, P. J. H. (2011) · InTech eBooks · doi:10.5772/25283 · Cited by 2
Psychiatric Disorders in Dementia
Vermeiren, Y., Dam, D. V., & Deyn, P. P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_11 · Cited by 1
Tau Pathology as a Target in Alzheimer's Therapeutics
Iqbal, K., & Grundke, I. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_14 · Cited by 1
A Current Understanding of Alzheimers Disease and the Prospects of Phytopharmacological Intervention as a Management Strategy
Juma, K. K. (2015) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000244 · Cited by 1
Modeling of Alzheimer’s disease using viral vectors
Stepanichev, M. Y. (2009) · Neurochemical Journal · doi:10.1134/s1819712409040035 · Cited by 1
Roles of the Tau Gene Short Tandem Repeats in Late-Onset Alzheimer's Disease
Dong, S., Chu, L., Liu, F., Zhu, X., Li, S., Zhang, Y., Wang, H., Cai, L., & Dai, M. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.648759 · Cited by 1
Semaphorins and Neurodegenerative Disorders
Okuno, T., & Nakatsuji, Y. (2015) · Springer eBooks · doi:10.1007/978-4-431-54385-5_10 · Cited by 1
In Vitro Aging Revisited: The Longevity of Cultured Neurons
Mori, N. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_5 · Cited by 1
Tea Polyphenolics and their Effect on Neurodegenerative Disorders-A Review
Bagchi, A., Swain, D. K., Bera, N., & Mitra, A. (2016) · Cited by 1
Natural Therapeutics for Alzheimer’s Disease
Dang, S., Mehtani, D., Kaur, A., & Gabrani, R. (2018) · Springer eBooks · doi:10.1007/978-981-13-1123-9_11 · Cited by 1
Mitochondrial abnormalities in neurological disorders
Ferreira, A. F. F., Singulani, M. P., & de Britto, L. R. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00012-9 · Cited by 1
Alzheimerʼs Disease
Schliebs, R. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_51 · Cited by 1
Direct Observation of Aggregation‐Induced Backbone Conformational Changes in Tau Peptides
Jiji, A. C., Shine, A., & Vijayan, V. (2016) · Angewandte Chemie · doi:10.1002/ange.201606544 · Cited by 1
The Risk Factors and Causes for Alzheimer’s Disease
Zhang, Y. (2022) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.220504.160 · Cited by 1
Investigación y terapias en la enfermedad de Alzheimer basadas en beta amiloide y tau
López-Camacho, P. Y., Guzmán-Hernández, R. N.-H., Gonzalez, V. H. H., Muñoz, J. E. D., García‐Sierra, F., & Basurto‐Islas, G. (2017) · Archivos de Neurociencias · doi:10.31157/an.v22i2.154 · Cited by 1
Isolation and Structural Elucidation of Unreported Prenylhydroquinone Glycoside from Sedum kamtschaticum Leaves and Its Effect on Hyperphosphorylated Tau Production in Aβ1–42-Treated SH-SY5Y Cells
Lee, S., Jeong, S. Y., Jang, Y. S., Cho, K., Lee, J., Lee, Y., & Kim, K. H. (2023) · Separations · doi:10.3390/separations10080428 · Cited by 1
The Presence and Impact of Bacteria and Biofilms in Chronic Skin and Systemic Diseases
Allen, H. B., Allen, R. A., Kannan, K., & Fransko, L. (2023) · Medical Research Archives · doi:10.18103/mra.v11i7.2.4160 · Cited by 1
Unraveling the Effects of SARS-CoV-2 on Dementia: A Comprehensive Study
Kadiri, S. K., & Tiwari, P. K. (2024) · Coronaviruses · doi:10.2174/0126667975329888241010115929 · Cited by 1
Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy
Lin, J., Lin, X., Fu, Y., Li, X., Li, X., Wang, Y., Zhao, L., Yu, S., & Piao, Y. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s495339 · Cited by 1
Dynamic Complexity and Causality Analysis of Scalp EEG for Detection of Cognitive Deficits
McBride, J. C. (2014) · Cited by 2
Therapeutical Implications of Melatonin in Alzheimer’s and Parkinson’s Diseases
Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M. F., & Brusco, L. I. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_9 · Cited by 1
NEUROINFLAMMATION AND INSULIN RESISTANCE IN ALZHEIMER’S DISEASE
М, П. М., Удк, & Альцгеймера, П. Б. (2014) · CyberLeninK (CyberLeninka) · Cited by 1
Tau in Tauopathies That Leads to Cognitive Disorders and in Cancer
Huda, M. N., & Pan, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74025 · Cited by 1
Alzheimer’s Disease: Future Efforts to Thwart Memory Loss
Allen, H. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.22.003738
Exploring novel autoantibodies within Alzheimer's disease
Falk, A. J. (2018) · Cited by 1
Some Noncommunicable Diseases of the Central Nervous System with a Possible Infectious Etiology (in Collaboration with V.A. Orlova, I.I. Mikhailova, A.A. Garbuzov, D.A. Khavkina, P.V. Chukhliaev, T.A. Ruzhentsova I. L. Naidenova, A. B. Danilov, A.V. Simonova, E.G. Filatova, I.A. Pavlovsky, O.V. Bystrova, A.M. Zatevalov, S.L. Bezrodny, T.Sh. Sadekov)
Zinserling, V. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-96260-9_20 · Cited by 1
The Historical Development of the Pathological Changes in Alzheimer’s Disease Based on Microbiology, Anatomy, and Physiology
Allen, H. B., & Allen, R. A. (2022) · Medical Research Archives · doi:10.18103/mra.v10i12.3423 · Cited by 1
Demenz bei Frauen und Männern: das gleiche Problem?
Miriam Kunz, A., & Lautenbacher, S. (2007) · Springer eBooks · doi:10.1007/978-3-540-71628-0_17 · Cited by 1
Análisis de polimorfismos de genes relacionados con la función endotelial y la muerte celular en demencia vascular y enfermedad de alzheimer
Manso-Calderón, R. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.123009 · Cited by 1
DENTAL MANAGEMENT OF PATIENTS WITH ALZHEIMER'S DISEASE
Santhosh, M. P., & Kumar, S. (2015) · Cited by 1
Evaluating the Therapeutic Effect of an Hsp90 Inhibitor in Mouse Models of Alzheimer’s Disease
Wang, B. (2016) · doi:10.21007/etd.cghs.2016.0412 · Cited by 1
Efficacy of Multifunctionalized Saccharide Constructs for the Attenuation of Amyloid-beta Toxicity
Dhavale, D. D. (2012) · Louisiana State University · doi:10.31390/gradschool_dissertations.2446 · Cited by 1
A freeze-and-thaw induced-fragment of the microtubule-associated protein Tau in rat brain extracts: implications for the biochemical assessment of neurotoxicityPreprint
Vasconcelos, I. C., de Campos, R. M., Schwaemmle, H. K., Masson, A. P., Ferrari, G. D., Alberici, L. C., Faça, V. M., Garcia-Cairasco, N., & Sebollela, A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/404129 · Cited by 1
Dysfunctional vascular smooth muscle cells mediate early and late-stage neuroinflammation and Tau hyperphosphorylationPreprint
Aguilar-Pineda, J. A., Vera-López, K. J., Shrivastava, P., Nieto-Montesinos, R., Chávez‐Fumagalli, M. Á., Dávila-Del-Carpio, G., Valdez, B. G., Miller, C. L., Malhotra, R. K., Lindsay, M. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.13.439741 · Cited by 1
Metabolic Abnormalities in Alzheimer Disease
Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 1
Role of microglia in myelin turnover
Safaiyan, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5727
Single cell transcriptomic profiling of tauopathy in a novel 3D neuron-astrocyte coculture modelPreprint
Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.03.490513 · Cited by 1
Characterization and Preclinical Treatment of Rotational Force-Induced Brain InjuryPreprint
Umfress, A., Chakraborti, A., Devi, S. P. S., Adams, R., Epstein, D., Massicano, A. V. F., Sorace, A. G., Singh, S., Hossian, M. I., Andrabi, S. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.20.500670 · Cited by 1
Curcumin ameliorate cortical histomorphological deficits in Streptozocin and western diet induced neurodegeneration in Wistar RatsPreprint
Mohammed, A. A., & Akinola, O. B. (2022) · Research Square · doi:10.21203/rs.3.rs-1739285/v1 · Cited by 1
Editorial: Neuropharmacological and neurotoxicological advances using in vivo non-mammalian model organisms
Xia, L., & Jin, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1264745 · Cited by 1
Nomethiazoles: PK/PD Study of a Novel Class of Alzheimer’s Disease Therapeutics
Tavassoli, E. (2012) · Figshare
Targeting Early Stages of Alzheimer’s Disease in a Transgenic Model
Lord, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Untersuchungen über die Auswirkungen von Geschlecht und genetischem Hintergrund auf die Alzheimerpathologie im 5xFAD-Mausmodell
Nordmeyer, P. J. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5124
Lítio e expressão gênica: implicações para a doença de Alzheimer.
Mendes, C. T. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2008.tde-10032009-113854
Caseína quinase 1 como alvo para o planejamento de fármacos em mal de Alzheimer
Rodrigues, R. P. (2014) · doi:10.11606/t.60.2014.tde-31102014-103834
Tau and neurofilament proteins in Alzheimer's disease and related cell models
Björkdahl, C. (2007) · Figshare
Meðferðarúrræði við Alzheimerssjúkdómnum : lyf og lyfleysur
Árnadóttir, E. S. (2014)
Construcción QSAR de redes complejas de compuestos de interés en Química Farmacéutica, Microbiología y Parasitología
Pintos, I. G. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Multilingualism and the risk of Alzheimer disease and dementia
Hack, E. E. (2011) · UWSpace (University of Waterloo)
CDNF in an experimental model of Parkinson's disease: studies on gene therapy and protein infusion
Bäck, S. (2014) · Työväentutkimus Vuosikirja
Inibição da fosfolipase A2 e fosforilação da proteína Tau em culturas primárias de neurônios hipocampais
de Paula, V. D. J. R. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-05032010-153937
Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease
Sundelöf, J. E. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Effects of Alzheimer s and Parkinson s disease gene mutation on cell signaling
Dehvari, N. (2009) · Figshare
LEPTIN RESISTANCE INDUCED OBESITY AND DIABETES PROMOTE NEUROPATHOLOGICAL CHANGES IN THE AGING BRAIN
Platt, T. L. (2014) · UKnowledge (University of Kentucky)
Amyloid β-Peptide and Central Cholinergic Neurons: Involvement in Normal Brain Function and Alzheimer’s Disease Pathology
Karn, S., Wei, Z., MacTavish, D., Kabogo, D., Song, M.-S., & Jhamandas, J. H. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_10
Role of P70 S6 kinase in the formation of tau pathologies in Alzheimer´s disease
An, W. (2005) · Figshare
Implications of cholesterol and cholesterol-lowering therapy in Alzheimer s disease
Famer, D. (2007) · Figshare
A Brief Introduction to the History of the β-Amyloid Protein (Aβ) of Alzheimer’s Disease
Small, D. H., & Barrow, C. J. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_1
Alterações neurogliais em ratos expostos ao ácido ocadáico como modelo de demência
Costa, A. P. (2011) · Americanae (AECID Library)
Análise da expressão gênica e proteômica em pacientes com doença de Alzheimer: busca de marcadores periféricos
Athié, M. C. P. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2010.tde-13082010-142129
El descubrimiento de nuevos fármacos en 2006.
Moreno, J. (2009)
Interactive mechanism between beta-amyloid process, alfa7 nicotinic receptor, glial cell activation and oxidative stress in Alzheimer's disease
Yu, W. (2006) · Figshare
Resting state brain networks and their implications in neurodegenerative disease
Sohn, W. S., Yoo, K., Kim, J., & Jeong, Y. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2000254
Investigations into the interaction between the beta-secretase protein BACE1 and a member of the reticulon family, RTN3
Weber, C. (2010) · University of Vienna · doi:10.25365/thesis.8628

Authors: Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., Tanimukai, H., & Grundke-Iqbal, I.
Affiliations: New York State Office for People With Developmental Disabilities (US)
Corresponding author: Iqbal, Khalid
ORCID: Iqbal, Khalid
Chohan, M. Omar
Gong, Cheng-Xin
Khatoon, Sabiha
Liu, Fei
Rahman, Abdur
Tanimukai, Hitoshi
Venue: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher: Elsevier BV
Published: 2005-01
Volume: 1739
Issue: 2-3
Pages: 198-210
ISSN: 0925-4439 (ISSN-L)
DOI: 10.1016/j.bbadis.2004.09.008
OpenAlex: W1998440070
Cited by: 1,037
References: 154
Citations by year: 2026: 28 · 2025: 48 · 2024: 50 · 2023: 67 · 2022: 60 · 2021: 60 · 2020: 57 · 2019: 58 · 2018: 64 · 2017: 48 · 2016: 48 · 2015: 54 · 2014: 52 · 2013: 48 · 2012: 52
FWCI: 3.38
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 3120 d)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute on Aging (AG19158, R01AG019158)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: tau protein, tauopathy, Alzheimer's disease, tau hyperphosphorylation, neurofibrillary tangles, paired helical filaments, microtubule stabilization, MAP2, tau kinases, protein phosphatase 2A, frontotemporal dementia, tau conformation, neurodegeneration, tau dephosphorylation, tau-targeted therapy
MeSH terms: Alzheimer Disease, Brain, Enzyme Inhibitors, Humans, Models, Biological, Nerve Degeneration, Neurofibrils, Phosphoprotein Phosphatases, Phosphorylation, Protein Conformation, Protein Kinases, Neurofibrillary Tangles, tau Proteins, Tauopathies, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tau pathology in Alzheimer disease and other tauopathies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks